Immediate Impact

4 by Nobel laureates 7 from Science/Nature 75 hit
Sub-graph 1 of 24

Citing Papers

Durability and efficacy of solbinsiran, a GalNAc-conjugated siRNA targeting ANGPTL3, in adults with mixed dyslipidaemia (PROLONG-ANG3): a double-blind, randomised, placebo-controlled, phase 2 trial
2025 Hit
From geroscience to precision geromedicine: Understanding and managing aging
2025 Hit
4 intermediate papers

Works of Stephen Donahue being referenced

Efficacy and Safety of Alirocumab in Adults With Homozygous Familial Hypercholesterolemia
2020
Pharmacokinetic and pharmacodynamic assessment of alirocumab in patients with familial hypercholesterolemia associated with proprotein convertase subtilisin/kexin type 9 gain-of-function or apolipoprotein B loss-of-function mutations
2019
and 1 more

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Stephen Donahue 579 278 177 166 142 31 1.1k
Wendy P. Battisti 557 1.0× 173 0.6× 200 1.1× 280 1.7× 183 1.3× 24 1.4k
Steven G. Simonson 408 0.7× 133 0.5× 189 1.1× 116 0.7× 168 1.2× 34 1.3k
Marcella A. Evans 513 0.9× 187 0.7× 113 0.6× 138 0.8× 214 1.5× 13 1.2k
Richard McLain 490 0.8× 178 0.6× 99 0.6× 189 1.1× 179 1.3× 25 933
Michael Igel 881 1.5× 93 0.3× 239 1.4× 246 1.5× 285 2.0× 18 1.5k
James M. Backes 478 0.8× 112 0.4× 73 0.4× 225 1.4× 127 0.9× 43 918
Maurice G. Emery 467 0.8× 173 0.6× 44 0.2× 192 1.2× 160 1.1× 50 1.0k
André Árpád Faludi 355 0.6× 64 0.2× 156 0.9× 232 1.4× 131 0.9× 42 987
Mohamed A. Omar 464 0.8× 135 0.5× 45 0.3× 113 0.7× 166 1.2× 31 968
Peter H. Jones 770 1.3× 221 0.8× 94 0.5× 348 2.1× 81 0.6× 13 1.1k

All Works

Loading papers...

Rankless by CCL
2026